Use of glucosamine and chondroitin in relation to mortality

Use of glucosamine and chondroitin in relation to mortality

Item
http://www.wikidata.org/entity/Q36570336
Developing criteria for evaluation of geroprotectors as a key stage toward translation to the clinicAssociations between glucosamine and chondroitin supplement use and biomarkers of systemic inflammationUnderstanding CAM Natural Health Products: Implications of Use Among Cancer Patients and Survivors.Randomized trial of glucosamine and chondroitin supplementation on inflammation and oxidative stress biomarkers and plasma proteomics profiles in healthy humans.Glucosamine sulfate suppresses the expression of matrix metalloproteinase-3 in osteosarcoma cells in vitro.Use of glucosamine and chondroitin supplements and risk of colorectal cancer.D-Glucosamine supplementation extends life span of nematodes and of ageing mice.The Rotterdam Study: 2014 objectives and design update.Simultaneous presentation of pancreatic cancer in a genetically unrelated couple.The use of dietary supplements among older persons in Southern Germany — Results from the KORA-age study
P2860

Use of glucosamine and chondroitin in relation to mortality

Item
http://www.wikidata.org/entity/Q36570336
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Use of glucosamine and chondroitin in relation to mortality
@ast
Use of glucosamine and chondroitin in relation to mortality
@en
type
label
Use of glucosamine and chondroitin in relation to mortality
@ast
Use of glucosamine and chondroitin in relation to mortality
@en
prefLabel
Use of glucosamine and chondroitin in relation to mortality
@ast
Use of glucosamine and chondroitin in relation to mortality
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P698
P932
P356
P1433
P1476
Use of glucosamine and chondroitin in relation to mortality
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P698
P932